Collection
Wellness Compounding Guide
An overview of GLP-focused metabolic protocols available under physician supervision.
Medical Disclaimer
The Wellness Compounding Guide is provided for educational and informational purposes only. It is not intended as medical advice, diagnosis, or treatment recommendations. GLP therapies should only be pursued under the guidance of a qualified, licensed healthcare professional who can evaluate your individual health history and goals. Individual results may vary, and not all compounds are appropriate for every person.
Always consult a physician or another qualified provider before starting, stopping, or modifying any wellness protocol.
GLP-1 & Metabolic
- Semaglutide
- GLP-1 receptor agonist used for appetite regulation, glycemic control, and sustained weight reduction.
- Tirzepatide
- Dual GIP/GLP-1 agonist offering enhanced metabolic and weight-loss effects versus GLP-1 alone.
- Retatrutide (R3-40)
- Investigational triple agonist (GIP/GLP-1/glucagon) targeting significant fat loss and metabolic remodeling.
- Cagrilintide
- Long-acting amylin analogue that enhances satiety and complements GLP-1 therapy.
- Tesofensine
- Monoamine reuptake inhibitor studied for appetite suppression and weight loss.
- SLU-PP-332
- ERR agonist that mimics exercise-like metabolic effects, supporting endurance and fat oxidation.
- BAM15
- Mitochondrial uncoupler that increases energy expenditure without stimulant effects.
- 5-Amino-1MQ (5-AMP)
- NNMT inhibitor supporting fat metabolism, muscle preservation, and cellular energy balance.
- Ondansetron
- 5-HT3 antagonist used to manage nausea, often paired with GLP-1 therapy.
For educational reference only. Not medical advice. Availability and Rx status vary by product.